mind & bodyWellcome Collection1957–1962 · Europe
Thalidomide's victims were born into an age without scans, and their mothers were left in the dark
Thalidomide was a sedative sold in the late 1950s, widely prescribed in Europe and elsewhere for morning sickness. Clinical testing was very limited, and nobody knew it could harm a foetus. It caused thousands of babies to be born with severe limb differences and other damage. There were no scans or antenatal tests then, so neither staff nor parents expected it, and mothers were often left isolated and waiting days to learn what had happened to their baby. Even after the cause became clear in 1961, information and support were slow to reach families.
The disaster led to far stricter drug testing and approval rules, including a requirement to prove safety in pregnancy. In the US, FDA reviewer Frances Kelsey had blocked approval of the drug.
The drug is still used today, in tightly controlled programmes, to treat leprosy complications and some cancers.
Wellcome Collection · CC BY 4.0
Illustrative photo · Gadogado123, CC BY-SA 4.0, via Wikimedia Commons
